Workflow
Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results
Prnewswire· 2025-08-13 20:05
Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 GuidanceMADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025.Key Fiscal Fourth Quarter Highlights Net revenue was $127.5 million, a decrease of 5 percent from the prior year period. Net income was $1.1 million compared to net income of $3.4 million in the prior year period. Adjusted EBITDA was $9.4 million compared to $ ...
Mondelēz International to Participate in Barclays Global Consumer Staples Conference on September 3, 2025
Globenewswire· 2025-08-13 20:05
CHICAGO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today announced that Dirk Van de Put, Chief Executive Officer and Luca Zaramella, Chief Financial Officer, will participate in a fireside chat session at the Barclays Global Consumer Staples Conference on Wednesday, September 3, 2025, at 8:15 am ET. A live audio webcast of the presentation will be available at www.mondelezinternational.com/investors. An archive of the webcast will be available on the company's website. Ab ...
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-08-13 20:05
–Completed enrollment in Phase 3 ONWARD clinical trials for envudeucitinib in moderate-to-severe plaque psoriasis; topline readout expected in early Q1 2026– –Completed enrollment in Phase 2b LUMUS clinical trial for envudeucitinib in systemic lupus erythematosus (SLE); topline readout expected in Q3 2026– –Completed merger with ACELYRIN, Inc. to strengthen financial position and support advancement of late-stage immunology pipeline– –Cash, cash equivalents and marketable securities of $486.3 million as of ...
Jianpu Technology Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend
Prnewswire· 2025-08-13 20:05
BEIJING, Aug. 13, 2025 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that FINRA has set September 9, 2025 as the ex-dividend date for the Company's special cash dividend to be paid in September 2025 that was announced on August 7, 2025. As the cash dividend of US$0.0995 per ordinary share, or US$1.99 per American depositary share ("ADS"), exceeds 25% of the Company's ADS price, FINRA has determined t ...
Aqua Metals Advances Commercialization of AquaRefining™ Technology with Industry-Leading Lithium Quality and Strategic Progress During Second Quarter of 2025
Globenewswire· 2025-08-13 20:05
Company eliminates long-term debt, strengthens balance sheet, and extends cash runway through asset sales and cost-reduction initiativesRENO, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable metals recycling, today announced financial results and operational highlights for the quarter ended June 30, 2025. The Company achieved significant progress toward commercialization, delivering best-in-class product quality, advancing ke ...
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-08-13 20:05
Phase 3 LEVEL Study Ongoing, Enrollment Completion (230 Patients) Expected in First Half of 2026, with Topline Data Expected in Second Half of 2026 On Track to Initiate Second Phase 3 Study, LEVEL-2, in 2025 CHAPEL HILL, N.C., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today reported financial results for th ...
Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates
Globenewswire· 2025-08-13 20:05
- Company now plans to share updated OS and PFS data from first-line pancreatic cancer patients (N = 34) treated with atebimetinib + mGnP in Q3 2025, earlier than prior guidance - - Exceptional 94% overall survival (OS) observed at 6 months in ongoing Phase 2a trial of atebimetinib plus modified Gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients (N = 34) - - Newly issued U.S. composition of matter patent for atebimetinib expected to provide exclusivity into 2042, with subsequent oppo ...
Burcon Announces Fiscal 2026 First Quarter Results
Newsfile· 2025-08-13 20:05
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal first quarter ended June 30, 2025."Burcon is entering a defining phase-evolving from technology pioneer to revenue-generating, innovation leader in plant protein," said Kip Underwood, Burcon's chief executive officer. "Following IFT FIRST, customer engagement has s ...
Robinhood Markets, Inc. Reports July 2025 Operating Data
Globenewswire· 2025-08-13 20:05
MENLO PARK, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for July 2025. Funded Customers at the end of July were 26.7 million (up about 160 thousand from June 2025, up approximately 2.5 million year-over-year).Total Platform Assets at the end of July were $298 billion (up 7% from June 2025, up 106% year-over-year). Net Deposits were $6.4 billion in July, or a 28% annualized growth rate relative to June 2025 Total ...
SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026
Prnewswire· 2025-08-13 20:05
BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology company, today announced its financial results for the second quarter ended June 30, 2025, and provided updated revenue guidance for 2025 and 2026.While second quarter revenue increased approximately 8.9% sequentially to $11.5 million, the Company's focus is on the significant momentum achieved since the quarter closed. SurgePays is on pace for record-breaking ...